title: Allosteric effectors influence the tetramer stability of both R- and T-states of hemoglobin A.
abstract: The contribution of heterotropic effectors to hemoglobin allostery is still not completely understood. With the recently proposed global allostery model, this question acquires crucial significance, because it relates tertiary conformational changes to effector binding in both the R- and T-states. In this context, an important question is how far the induced conformational changes propagate from the binding site(s) of the allosteric effectors. We present a study in which we monitored the interdimeric interface when the effectors such as Cl-, 2,3-diphosphoglycerate, inositol hexaphosphate, and bezafibrate were bound. We studied oxy-Hb and a hybrid form (alphaFeO2)2-(betaZn)2 as the T-state analogue by monitoring heme absorption and Trp intrinsic fluorescence under hydrostatic pressure. We observed a pressure-dependent change in the intrinsic fluorescence, which we attribute to a pressure-induced tetramer to dimer transition with characteristic pressures in the 70-200-megapascal range. The transition is sensitive to the binding of allosteric effectors. We fitted the data with a simple model for the tetramer-dimer transition and determined the dissociation constants at atmospheric pressure. In the R-state, we observed a stabilizing effect by the allosteric effectors, although in the T-analogue a stronger destabilizing effect was seen. The order of efficiency was the same in both states, but with the opposite trend as inositol hexaphosphate > 2,3-diphosphoglycerate > Cl-. We detected intrinsic fluorescence from bound bezafibrate that introduced uncertainty in the comparison with other effectors. The results support the global allostery model by showing that conformational changes propagate from the effector binding site to the interdimeric interfaces in both quaternary states.
authors.affiliation: Department of Biophysics and Radiation Biology and Biophysics Research Group of the Hungarian Academy of Sciences, Faculty of Medicine, Semmelweis University, P. O. Box 263 H 1444 Budapest, Hungary.
authors.forename: Gusztáv
authors.initials: G
authors.lastname: Schay
authors.forename: László
authors.initials: L
authors.lastname: Smeller
authors.forename: Antonio
authors.initials: A
authors.lastname: Tsuneshige
authors.forename: Takashi
authors.initials: T
authors.lastname: Yonetani
authors.forename: Judit
authors.initials: J
authors.lastname: Fidy
mesh_terms: D019794:2,3-Diphosphoglycerate / Q000737:chemistry / Q000378:metabolism*; D000494:Allosteric Regulation; D000818:Animals; D001629:Bezafibrate / Q000737:chemistry / Q000378:metabolism*; D001665:Binding Sites; D002712:Chlorides / Q000737:chemistry / Q000378:metabolism*; D019281:Dimerization; D006441:Hemoglobin A / Q000737:chemistry / Q000378:metabolism; D006736:Horses; D006801:Humans; D000960:Hypolipidemic Agents / Q000737:chemistry / Q000378:metabolism*; D008958:Models, Molecular; D009211:Myoglobin / Q000737:chemistry / Q000378:metabolism; D010084:Oxidation-Reduction; D010833:Phytic Acid / Q000737:chemistry / Q000378:metabolism*; D011166:Porphyrins / Q000737:chemistry; D011485:Protein Binding; D020836:Protein Structure, Quaternary; D013050:Spectrometry, Fluorescence; D014364:Tryptophan / Q000737:chemistry
chemical_list: D002712:Chlorides; D000960:Hypolipidemic Agents; D009211:Myoglobin; D011166:Porphyrins; D019794:2,3-Diphosphoglycerate; D010833:Phytic Acid; D014364:Tryptophan; D006441:Hemoglobin A; D001629:Bezafibrate